All costs in the program version of the DATCAP are estimated from the perspective
of the program, rather than the perspective of the client, the payer (such as
the private or public insurer), or society.
To broaden the measurement perspective, a supplemental version of the DATCAP
was designed to explicitly measure costs incurred by the patient attending
treatment. The Client DATCAP consists of two separate versions: Client
DATCAP (Inpatient) and Client DATCAP (Outpatient).
Client DATCAP (Inpatient) was designed to measure costs
incurred by patients attending inpatient treatment, such as inpatient
detoxification, residential, inpatient hospital, and therapeutic community.
Client DATCAP (Outpatient) was designed to
measure costs incurred by patients attending outpatient treatment, such as
drug-free, methadone, day treatment, and intensive outpatient modalities.
first set of cost-related questions applies to the opportunity cost of time in
treatment (e.g., wages). The second category applies to any expenditures
incurred as a result of attending treatment, such as childcare, elderly care,
and transportation costs.
In addition to questions related to resources used in attending treatment,
both versions also contain questions on socio-demographics and treatment length-of-stay.
The Client DATCAP is currently being pilot tested at several treatment programs
in the United States. Therefore, the instruments provided below
are preliminary test versions of the Client DATCAP.
The Client DATCAP is now available in Spanish.